No Data
No Data
Express News | Novo's Weight-Loss Drug Wegovy Receives UK Nod For Heart Disease
Eli Lilly, Novo Are Weight-Loss Winners. Rivals Won't Be an Issue for Years: Analyst. -- Barrons.com
Market Whales and Their Recent Bets on LLY Options
Eli Lilly (LLY) Advances But Underperforms Market: Key Facts
AnaptysBio Investigational Arthritis Drug Might Have Better Efficacy Profile Than Eli Lilly's: Analyst
The S&P 500 Typically Outperforms in July, Underperforms August-October - RBC Capital Markets
No Data